Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Ethinyl estradiol / norelgestromin price, strengths & recalls

Generic of Xulane, Zafemy

Pharmacies pay $93.95 for 3 pouches of Ethinyl estradiol / norelgestromin 0.00146 mg/hr / 0.00625 mg/hr (168 hr) patch this week. 3 manufacturers make it. Its official label last changed on April 17, 2026.

Generic
Pharmacies pay$93.95for 3 pouches of 0.00146 mg/hr / 0.00625 mg/hr (168 hr) patch-5.9% in 4 weeks
Fair cash price
$118.54
Strengths
1
Makers
3
Updated
Nov 11

Ethinyl estradiol / norelgestromin price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.00146 mg/hr / 0.00625 mg/hr (168 hr) patch$31.32$93.95 / 3 pouches-5.9%-14.1%

Brand names of ethinyl estradiol / norelgestromin

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

No shortage reportedChecked Nov 17, 2026
No ongoing recallsNone on record

What did you pay for ethinyl estradiol / norelgestromin? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedApril 17, 2026
Version3 of 3
EffectiveApr 16, 2026
Read the label

These highlights do not include all the information needed to use NORELGESTROMIN AND ETHINYL ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for NORELGESTROMIN AND ETHINYL ESTRADIOL TRANSDERMAL SYSTEM NORELGESTROMIN AND ETHINYL ESTRADIOL transdermal systemInitial U.S. Approval: 2001

This drug has a boxed warning

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI |GTE 30 kg/m2

• Cigarette Smoking and Serious Cardiovascular Events

Cigarette smoking increases the risk of serious cardiovascular events from hormonal contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, CHCs, including norelgestromin and ethinyl estradiol transdermal system, are contraindicated in women who are over 35 years of age and smoke [see Contraindications (4) and Warnings and Precautions (5.1)].

• Contraindicated in Women with a BMI ≥ 30 kg/m2

Norelgestromin and ethinyl estradiol transdermal system is contraindicated in women with a BMI ≥ 30 kg/m2. The risk of VTE may be greater with norelgestromin and ethinyl estradiol transdermal in women with a BMI ≥ 30 kg/m2 compared to women with a lower BMI [see Contraindications (4) and Warnings and Precautions (5.1)].

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI ≥ 30 kg/m2

See full prescribing information for complete boxed warning.

● Norelgestromin and ethinyl estradiol transdermal is contraindicated in women over 35 years old who smoke. Cigarette smoking increases the risk of serious cardiovascular events from combination hormonal contraceptive (CHC) use. (4, 5.1)

● Norelgestromin and ethinyl estradiol transdermal is contraindicated for use in women with a BMI ≥ 30 kg/m2. Women with a BMI ≥ 30 kg/m2who use norelgestromin and ethinyl estradiol transdermal may have a higher risk of venous thromboembolic events compared with women with a lower BMI. (4, 5.1, 8.8)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
3 approved generic applications on the market

Ethinyl estradiol / norelgestromin questions

How much does ethinyl estradiol / norelgestromin cost without insurance?

Pharmacies pay about $93.95 for 3 pouches of ethinyl estradiol / norelgestromin 0.00146 mg/hr / 0.00625 mg/hr (168 hr) patch ($31.32 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $118.54. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of ethinyl estradiol / norelgestromin?

Ethinyl estradiol / norelgestromin is sold as Xulane, Zafemy. The generic has the same active ingredient and usually costs far less.

Is ethinyl estradiol / norelgestromin in shortage?

No shortage is reported for ethinyl estradiol / norelgestromin right now. We check the national shortage list every day.

Has ethinyl estradiol / norelgestromin been recalled?

No recalls are on record for ethinyl estradiol / norelgestromin.

When did the ethinyl estradiol / norelgestromin label last change?

The official label was last updated on April 17, 2026 (version 3). See what changed.

Talk about ethinyl estradiol / norelgestromin

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.